The future of diagnosing NASH - could a simple blood test be the key?
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The future of diagnosing NASH - could a simple blood test be the key?
Authors
Keywords
-
Journal
Expert Review of Gastroenterology & Hepatology
Volume 11, Issue 11, Pages 995-997
Publisher
Informa UK Limited
Online
2017-09-02
DOI
10.1080/17474124.2017.1374851
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis
- (2017) Cristina Alonso et al. GASTROENTEROLOGY
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis
- (2017) Parambir S. Dulai et al. HEPATOLOGY
- Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis
- (2016) Stuart McPherson et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Fibrogenesis assessed by serological type III collagen formation identifies patients with progressive liver fibrosis and responders to a potential antifibrotic therapy
- (2016) Morten A. Karsdal et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease
- (2016) Joel T. Haas et al. Annual Review of Physiology
- Noninvasive Detection of Nonalcoholic Steatohepatitis Using Clinical Markers and Circulating Levels of Lipids and Metabolites
- (2016) You Zhou et al. Clinical Gastroenterology and Hepatology
- Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease
- (2016) Timothy Hardy et al. GUT
- The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- Molecular regulation of miRNAs and potential biomarkers in the progression of hepatic steatosis to NASH
- (2015) Yuping Wang et al. Biomarkers in Medicine
- Liver Histology and Clinical Trials for Nonalcoholic Steatohepatitis-Perspectives From 2 Pathologists
- (2015) David E. Kleiner et al. GASTROENTEROLOGY
- Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
- (2015) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: Findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint Workshop
- (2015) Arun J. Sanyal et al. HEPATOLOGY
- PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis
- (2015) Sven Francque et al. JOURNAL OF HEPATOLOGY
- Current efforts and trends in the treatment of NASH
- (2015) Vlad Ratziu et al. JOURNAL OF HEPATOLOGY
- Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications
- (2015) Stefano Ballestri et al. Expert Review of Gastroenterology & Hepatology
- A Pilot Study of Serum MicroRNAs Panel as Potential Biomarkers for Diagnosis of Nonalcoholic Fatty Liver Disease
- (2014) Youwen Tan et al. PLoS One
- Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
- (2013) An Verrijken et al. HEPATOLOGY
- Noninvasive Assessment of Nonalcoholic Fatty Liver Disease in Obese or Overweight Patients
- (2012) Sven M.A. Francque et al. Clinical Gastroenterology and Hepatology
- N-glycan based biomarker distinguishing non-alcoholic steatohepatitis from steatosis independently of fibrosis
- (2011) Bram Blomme et al. DIGESTIVE AND LIVER DISEASE
- Endpoints and clinical trial design for nonalcoholic steatohepatitis
- (2011) Arun J. Sanyal et al. HEPATOLOGY
- C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients
- (2011) Esther Zimmermann et al. JOURNAL OF HEPATOLOGY
- Visceral adiposity and insulin resistance are independent predictors of the presence of non-cirrhotic NAFLD-related portal hypertension
- (2010) S Francque et al. INTERNATIONAL JOURNAL OF OBESITY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now